- ￥1600 - 2650
- MultiSciences
- 31.25 pg/mL - 2000 pg/mL
- 杭州
- EK283
- 2026年01月18日
企业认证
研选同类产品更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 用户评价
- 文献和实验
- 技术资料
- 库存：
99
- 供应商：
联科生物
- 检测范围：
31.25 pg/mL - 2000 pg/mL
- 检测方法：
双抗夹心法
- 应用：
ELISA
- 适应物种：
Mouse
- 标记物：
HRP
- 样本：
血清，血浆，细胞培养上清及其他生物学样本
- 规格：
96T/48T
| 规格： | 96T | 产品价格： | ￥2650.0 |
|---|---|---|---|
| 规格： | 48T | 产品价格： | ￥1600.0 |
| 背景介绍 | 血管内皮生长因子(VEGF)是生长因子的亚家族，具体来说，属于胱氨酸结生长因子中的血小板衍生生长因子(PDGF)家族。它们是重要的信号转导蛋白，参与血管发生(胚胎循环系统从头形成)和血管生成(从已存在的脉管系统生长形成血管)。VEGF可刺激血管发生和血管生成。当血液循环不足时，可参与回复组织供氧系统。VEGF最主要的作用是血管生成。在胚胎形成期，VEGF调控内皮细胞的增殖、迁移和存活，从而调控血管密度和大小，但无法决定血管的类型。在支气管哮喘和糖尿病患者的血清中含有高浓度VEGF。当VEGF过表达时会引起疾病。供血不足时，实体肿瘤的大小受限；而表达VEGF的肿瘤则会不断生长并发生转移。VEGF过表达会导致眼睛视网膜和身体其他部分的血管性疾病。贝伐珠单抗和雷珠单抗可抑制VEGF，并控制或减缓疾病进程。 |
| 检测原理 | 本试剂盒采用双抗体夹心酶联免疫吸附检测技术。特异性抗小鼠VEGF抗体预包被在高亲和力的酶标板上。酶标板孔中加入标准品、待测样本和生物素化的检测抗体，经过孵育，样本中存在的VEGF与固相抗体和检测抗体结合。洗涤去除未结合的物质后，加入辣根过氧化物酶标记的链霉亲和素(Streptavidin-HRP)。洗涤后，加入显色底物TMB，避光显色。颜色反应的深浅与样本中VEGF的浓度成正比。加入终止液终止反应，在450 nm波长(参考波长570-630 nm)测定吸光度值。 |
| 组分 | 包被抗VEGF单克隆抗体的96孔聚苯乙烯酶标板 小鼠VEGF冻干标准品 VEGF 检测抗体 标准品稀释液 检测缓冲液(10×) 底物(TMB) 终止液 洗液(20×) 封板膜 |
| 分析类型 | 夹心ELISA |
| 样本类型 | 血清、血浆，细胞培养上清及其他生物学样本 |
| 板式 | 96孔板，可拆 |
| 保存 | 试剂盒未拆开，4℃保存。已拆开，标准品-20℃保存，其它4℃保存。 |
| 运输条件 | 4℃蓝冰运输 |
| 样本体积 | 20 μl |
| 灵敏度 | 1.97 pg/ml |
| 标曲图 |  |
| 标准曲线范围 | 31.25-2000pg/ml |
| 回收率范围 | 89%-110% |
| 平均回收率 | 0.98 |
| 板间变异系数 | 3.8%-7.6% |
| 板内变异系数 | 2.3%-5.2% |
VEGFA 分子靶点信息概述
- 分子名：VEGFA, vascular endothelial growth factor A
- 基因家族：VEGF family
- 别名：VEGF-A; VPF
- 曾用名：VEGF
- 全称：vascular endothelial growth factor
VEGFA 分子靶点综述
血管内皮生长因子(VEGF)是生长因子的亚家族，具体来说，属于胱氨酸结生长因子中的血小板衍生生长因子(PDGF)家族。它们是重要的信号转导蛋白，参与血管发生(胚胎循环系统从头形成)和血管生成(从已存在的脉管系统生长形成血管)。VEGF可刺激血管发生和血管生成。当血液循环不足时，可参与回复组织供氧系统。VEGF最主要的作用是血管生成。在胚胎形成期，VEGF调控内皮细胞的增殖、迁移和存活，从而调控血管密度和大小，但无法决定血管的类型。在支气管哮喘和糖尿病患者的血清中含有高浓度VEGF。当VEGF过表达时会引起疾病。供血不足时，实体肿瘤的大小受限；而表达VEGF的肿瘤则会不断生长并发生转移。VEGF过表达会导致眼睛视网膜和身体其他部分的血管性疾病。贝伐珠单抗和雷珠单抗可抑制VEGF，并控制或减缓疾病进程。
小鼠 Mouse Vegfa 分子靶点信息
- 分子名：Vegfa, vascular endothelial growth factor A
- 别称：
- vascular endothelial growth factor
- Vegf
- VEGF-A
- VEGF120
- VEGF164
- VEGF188
- VPF
- 基因序列：NCBI_Gene: 22339
- 蛋白序列：
- UniprotKB: Q00731
- UniprotKB: A0FKR4
- UniprotKB: E9Q4N8
- UniprotKB: E9Q4N9
- UniprotKB: F8T7H0
- UniprotKB: F8WH10
- UniprotKB: F8WH81
- UniprotKB: Q5UD54
- UniprotKB: Q6YLN3
小鼠 Mouse Vegfa 靶点分子功能（预测）
Enables extracellular matrix binding activity; heparin binding activity; and signaling receptor binding activity. Involved in several processes, including generation of neurons; regulation of signal transduction; and vasculature development. Acts upstream of or within several processes, including animal organ development; positive regulation of cell population proliferation; and vasculature development. Located in cytoplasm; extracellular space; and nucleus. Is expressed in several structures, including alimentary system; brain; egg cylinder; genitourinary system; and heart. Used to study DiGeorge syndrome; amyotrophic lateral sclerosis type 1; newborn respiratory distress syndrome; and psoriasis. Human ortholog(s) of this gene implicated in several diseases, including artery disease (multiple); autoimmune disease (multiple); gastrointestinal system cancer (multiple); hematologic cancer (multiple); and reproductive organ cancer (multiple). Orthologous to human VEGFA (vascular endothelial growth factor A).
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
用户评价
暂无用户评价
文献和实验- IF = 20.722 Fullerenols boosting the therapeutic effect of anti-CD47 antibody to trigger robust anti-tumor immunity by inducing calreticulin exposure. Nano Today (2021)
- IF = 18.808 Green Tea Derivative Driven Smart Hydrogels with Desired Functions for Chronic Diabetic Wound Treatment. ADVANCED FUNCTIONAL MATERIALS (2021)
- IF = 14 Liposome-anchored mesenchymal stem cells for radiation pneumonia/fibrosis treatment. BIOMATERIALS (2023)
- IF = 13.801 Anticoagulants Enhance Molecular and Cellular Immunotherapy of Cancer by Improving Tumor Microcirculation Structure and Function and Redistributing Tumor Infiltrates. CLINICAL CANCER RESEARCH (2023)
- IF = 13.273 Exosomes laden self-healing injectable hydrogel enhances diabetic wound healing via regulating macrophage polarization to accelerate angiogenesis. CHEMICAL ENGINEERING JOURNAL (2021)
- IF = 11.322 Low-fouling granular hydrogel for efficient preparation and delivery of stem cell spheroids towards wound treatment. COMPOSITES PART B-ENGINEERING (2022)
- IF = 8.537 Harmine enhances type H vessel formation and prevents bone loss in ovariectomized mice. Theranostics (2018)
- IF = 8.5 Endothelial Stat3 activation promotes osteoarthritis development. CELL PROLIFERATION (2023)
- IF = 8.079 Intramyocardial injected human umbilical cord-derived mesenchymal stem cells (HucMSCs) contribute to the recovery of cardiac function and the migration of CD4+ T cells into the infarcted heart via CCL5/CCR5 signaling. Stem Cell Research & Therapy (2022)
- IF = 8.079 Melatonin enhances autologous adipose-derived stem cells to improve mouse ovarian function in relation to the SIRT6/NF-κB pathway. Stem Cell Research & Therapy (2022)
- IF = 8.079 Mesenchymal stromal cells pretreated with proinflammatory cytokines enhance skin wound healing via IL-6-dependent M2 polarization. Stem Cell Research & Therapy (2022)
- IF = 7.917 Reprogramming tumor microenvironment via dual targeting co-delivery of regorafenib and alpha-difluoromethylornithine in osteosarcoma. Cancer Nanotechnology (2023)
- IF = 7.571 Hypoxia inducible factor-1 signaling pathway in macrophage involved angiogenesis in materials-instructed osteo-induction. Journal of Materials Chemistry B (2022)
- IF = 7.561 Cytokine Signature Induced by SARS-CoV-2 Spike Protein in a Mouse Model. Frontiers in Immunology (2021)
- IF = 7.561 Three-Dimensional Culture Decreases the Angiogenic Ability of Mouse Macrophages.. Frontiers in Immunology (2021)
- IF = 7.419 Systemic pharmacological verification of Salvia miltiorrhiza-Ginseng Chinese herb pair in inhibiting spontaneous breast cancer metastasis. BIOMEDICINE & PHARMACOTHERAPY (2022)
- IF = 7.169 Targeted VEGFA therapy in regulating early acute kidney injury and late fibrosis. ACTA PHARMACOLOGICA SINICA (2023)
- IF = 6.684 Three-Dimensionally Printed Ti2448 With Low Stiffness Enhanced Angiogenesis and Osteogenesis by Regulating Macrophage Polarization via Piezo1/YAP Signaling Axis. Frontiers in Cell and Developmental Biology (2021)
- IF = 6.491 Inhibition of dipeptidyl peptidase IV prevents high fat diet-induced liver cancer angiogenesis by downregulating chemokine ligand 2. CANCER LETTERS (2018)
- IF = 6.147 Uniformly Sized Stem Cell Spheroids for Treatment of Hind Limb Ischemia: Size Effect. Advanced Materials Interfaces (2022)
- IF = 5.753 Helicobacter pylori induces gastric cancer via down-regulating miR-375 to inhibit dendritic cell maturation. HELICOBACTER (2021)
- IF = 5.714 P-Hydroxylcinnamaldehyde induces tumor-associated macrophage polarization toward the M1 type by regulating the proteome and inhibits ESCC in vivo and in vitro. INTERNATIONAL IMMUNOPHARMACOLOGY (2023)
- IF = 5.682 GIT1 protects traumatically injured spinal cord by prompting microvascular endothelial cells to clear myelin debris. Aging-US (2021)
- IF = 5.5 Inhibition of Src Homology 2 Domain-Containing Protein Tyrosine Phosphatase-2 Facilitates CD31hiEndomucinhi Blood Vessel and Bone Formation in Ovariectomized Mice. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2018)
- IF = 5.422 The Intracellular Interaction of Porcine β-Defensin 2 with VASH1 Alleviates Inflammation via Akt Signaling Pathway. JOURNAL OF IMMUNOLOGY (2022)
- IF = 5.344 Macrophage polarization plays roles in bone formation instructed by calcium phosphate ceramics. Journal of Materials Chemistry B (2020)
- IF = 5.34 ACSL4 promotes colorectal cancer and is a potential therapeutic target of Emodin. PHYTOMEDICINE (2022)
- IF = 5.275 Alkaloid derivative ION-31a inhibits breast cancer metastasis and angiogenesis by targeting HSP90α. BIOORGANIC CHEMISTRY (2021)
- IF = 5.131 Aucubin Impeded Preosteoclast Fusion and Enhanced CD31hi EMCNhi Vessel Angiogenesis in Ovariectomized Mice. Stem Cells International (2022)
- IF = 4.432 17β-Estradiol promotes angiogenesis of stria vascular in cochlea of C57BL/6J mice. EUROPEAN JOURNAL OF PHARMACOLOGY (2021)
- IF = 4.36 Amelioration of diabetic retinopathy in db/db mice by treatment with different proportional three active ingredients from Tibetan medicine Berberis dictyophylla F. JOURNAL OF ETHNOPHARMACOLOGY (2021)
- IF = 4.152 Knockdown of AK142426 suppresses M2 macrophage polarization and inflammation in peritoneal fibrosis via binding to c-Jun. JOURNAL OF GENE MEDICINE (2023)
- IF = 4.152 Macrophage Polarization Mediated by Chitooligosaccharide (COS) and Associated Osteogenic and Angiogenic Activities. ACS Biomaterials Science & Engineering (2020)
- IF = 4.147 The coupling of reduced type H vessels with unloading-induced bone loss and the protection role of Panax quinquefolium saponin in the male mice. BONE (2020)
- IF = 4.122 Amelioration of diabetic nephropathy in db/db mice treated with tibetan medicine formula Siwei Jianghuang Decoction Powder extract. Scientific Reports (2018)
- IF = 3.776 Fabrication of Biomolecule-Loaded Composite Scaffolds Carried by Extracellular Matrix Hydrogel. Tissue Engineering Part A (2020)
- IF = 3.743 Bu-Shen-Yi-Qi formula ameliorates airway remodeling in murine chronic asthma by modulating airway inflammation and oxidative stress in the lung. BIOMEDICINE & PHARMACOTHERAPY (2019)
- IF = 3.414 Amelioration of dry eye syndrome in db/db mice with diabetes mellitus by treatment with Tibetan Medicine Formula Jikan Mingmu Drops. JOURNAL OF ETHNOPHARMACOLOGY (2019)
- IF = 3.244 Bone Marrow-Derived Mesenchymal Stem Cells Modified with Akt1 Ameliorates Acute Liver GVHD. BIOLOGICAL PROCEDURES ONLINE (2019)
- IF = 3.188 Silencing of LncRNA steroid receptor RNA activator attenuates polycystic ovary syndrome in mice. BIOCHIMIE (2018)
- IF = 3.06 Yifei Tongluo, a Chinese Herbal Formula, Suppresses Tumor Growth and Metastasis and Exerts Immunomodulatory Effect in Lewis Lung Carcinoma Mice. MOLECULES (2019)
- IF = 2.955 MicroRNA-155 Inhibits Polarization of Macrophages to M2-Type and Suppresses Choroidal Neovascularization. INFLAMMATION (2017)
- IF = 2.914 Effects of combined traffic noise on the synaptic ultrastructure and expressions of p-CaMKII and NMDAR1 in the hippocampus of young SD rats. ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH (2019)
- IF = 2.892 The multiple organs insult and compensation mechanism in mice exposed to hypobaric hypoxia. CELL STRESS & CHAPERONES (2020)
- IF = 2.189 The histologic reaction and permanence of hyaluronic acid gel, calcium hydroxylapatite microspheres, and extracellular matrix bio gel. Journal of Cosmetic Dermatology (2023)
- IF = 0 Macrophage Spheroids with Chronological Phenotype Shifting To Promote Therapeutic Angiogenesis in Critical Limb Ischemia. ACS Applied Bio Materials (2020)
小鼠 血管内皮生长因子（VEGF) 酶联免疫 分析（ ELISA ） 试剂 盒使用说明书 本试剂仅供研究使用 目的：本试剂盒用于测定小鼠血清，血浆及相关液体样本中 血管内皮生长因子（VEGF) 含量。 实验原理 ： 本试剂盒应用双抗体夹心法测定 标本 中 小鼠 血管内皮生长因子（VEGF) 水平。用纯化的 小鼠 血管内皮生长因子（VEGF) 抗体包被微孔板，制成固相抗体，往包被单抗的微孔中依次加入 小鼠 血管内皮生长因子
上海西唐生物科技有限公司 021-55229872, 65333639 www.westang.com 小鼠血管内皮生长因子 ( VEGF )ELISA 试剂盒 ( 用于血清、血浆、细胞培养上清液和其它生物体液内 ) 原理 本实验采用双抗体夹心 ABC-ELISA 法。用抗小鼠 VEGF 单抗包被于酶标板上，标准品和样品中的 VEGF与单抗结合，加入生物素化的抗小鼠
小鼠血管内皮生长因子-A(VEGF-A)ELISA试剂盒 说明书
上海西唐生物科技有限公司 021-55229872, 65333639 www.westang.com 小鼠血管内皮生长因子-A ( VEGF-A )ELISA 试剂盒 ( 用于血清、血浆、细胞培养上清液和其它生物体液内 ) 原理 本实验采用双抗体夹心 ABC-ELISA 法。用抗小鼠 VEGF-A 单抗包被于酶标板上，标准品和样品中的 VEGF-A与单抗结合
技术资料需要更多技术资料 索取更多技术资料
